TAKEDA PHARMACEUTICAL CO LTD
Q1 2025 13F Holdings
- Locationtokyo, M0
- Num holdings
11
- Value ($000)
$16,194
- Date Filed05/12/2025
- Form type13F-HR
- CIK0001395064
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HLVX HilleVax, Inc. | COM | 43157M102 | $9.75 M | 60 % | 6,724,000 | ||
OVID Ovid Therapeutics, Inc. | COM | 690469101 | $2.35 M | 15 % | 7,531,996 | ||
XLO Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | COM | 98422T100 | $1.07 M | 7 % | 1,475,121 | ||
EQ Equillium, Inc. | COM | 29446K106 | $711.74 K | 4 % | 1,824,977 | ||
AMWL American Well Corporation | COM | 03044L204 | $612.54 K | 4 % | 77,733 | ||
STTK Shattuck Labs, Inc. | COM | 82024L103 | $489.84 K | 3 % | 515,619 | ||
LYEL Lyell Immunopharma, Inc. | COM | 55083R104 | $442.94 K | 3 % | 823,317 | ||
TSBX Turnstone Biologics | COM | 90042W100 | $367.29 K | 2 % | 895,824 | ||
RANI Rani Therapeutics Holdings, Inc. | COM | 753018100 | $256.02 K | 2 % | 203,190 | ||
Third Harmonic Bio, Inc. | COM | 88427A107 | $127.82 K | 1 % | 36,835 |
Rows Per Page
10
- 10
- 50
- 100